Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2019
Price : $35 *
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ULTRA-ZET
- 26 Mar 2019 Status changed from recruiting to completed.
- 24 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 30 Nov 2013 Planned number of patients changed from 116 to 1116.